HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT Newswires Live
2024-12-24

HCW Biologics (HCWB) fell nearly 11% in recent Monday trading after the company said it received a delisting notice from Nasdaq.

The company said it faces potential delisting following its failure to regain compliance with Nasdaq's requirements for continued listing. It was notified in June by exchange regulators that its market value of listed securities, or MVLS, was below the required $50 million threshold for 30 straight business days.

HCW Biologics said it intends to timely request a hearing before the Nasdaq Hearing Panel to avoid delisting and to discuss how it plans to regain compliance with the MVLS rule.

Price: 0.40, Change: -0.05, Percent Change: -10.91

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10